A Prospective, Open-label, Multicenter, International Follow-up Study on the Safety and Efficacy of Enteric-coated Mycophenolate Sodium (EC-MPS) in Kidney Transplant Recipients.
Phase of Trial: Phase IV
Latest Information Update: 28 Jan 2011
At a glance
- Drugs Mycophenolate sodium (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Sponsors Novartis
- 28 Jan 2011 Actual end date (Jan 2005) added as reported by ClinicalTrials.gov.
- 28 Jan 2011 Actual initiation date changed from Nov 2002 to Aug 2002 as reported by ClinicalTrials.gov.
- 28 Jan 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.